Inloggen
Inloggen
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registreer
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepagina
  2. Aandelen
  3. China
  4. Shanghai Stock Exchange
  5. Dizal (Jiangsu) Pharmaceutical Co., Ltd.
  6. Nieuws
  7. Andere talen
    688192   CNE1000055W8

DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.

(688192)
  Rapport
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenFonds 
OverzichtAl het nieuwsAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
Nieuws in andere talen op DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.
05/09Dizal Pharmaceutical Co., Ltd. Announces Sunvozertinib Meets Primary Endpoint in Its Fi..
05/09Dizal Announces Positive Phase I Clinical Trial Results for DZD1516 in Treating HER2 Br..
25/08Dizal Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30..
05/08Dizal Demonstrates Clinical Update for Sunvozertinib in Platinum-Pretreated NSCLC Patie..
05/05Dizal Pharmaceutical Announces Pre-Clinical and Clinical Results of Sunvozertinib Publi..
27/04Dizal Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended Mar..
25/02Dizal Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended Decembe..
18/02Dizal Pharmaceutical Receives U.S. FDA Fast Track Designation for Dzd4205 for the Treat..